WHO ICTRP trial
Comparison of Tranexamic Acid and Nitroglycerine and Remifentanil in prevention…
IRCT20141209020258N159 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20141209020258N159 |
|---|---|
| Public title | Comparison of Tranexamic Acid and Nitroglycerine and Remifentanil in prevention of bleeding during herniated lumbar intervertebral disc surgery |
| Scientific title | Comparison of Tranexamic Acid and Nitroglycerine and Remifentanil in prevention of bleeding during herniated lumbar intervertebral disc surgery |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Herniated lumbar intervertebral disc. Other intervertebral disc displacement, lumbar region;M51.26 |
| Interventions | Intervention 1: Intervention group 1: We will be infusion a bolus dose of 10 milliliter of normal saline is administered for 10 minutes and then remifentanil is infused at a dose of 0.1 micrograms in kilogram in minute until the end of… |
| Registration date | Jun 2, 2021 |
| Target size | 135 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: